BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SLC12A1
,
Response to oxidative stress
,
Leukemia
,
Adipose tissue
,
Biofuel
,
Fluoxetine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hiv protease
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
PBMCs from HIV patients before and after antiretroviral therapy
Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Affymetrix]
Broad Connectivity Map (CMAP 2.0) compound database
Cortical neuron cells treated with SBI-0206965 Lopinavir and O151 cocktail
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
A drug discovery platform: a simplified immunoassay for analyzing HIV protease activity.
HIV-1 protease cleavage site prediction based on two-stage feature selection method.
Design and synthesis of HIV-1 protease inhibitors for a long-acting injectable drug application.
Interaction of I50V mutant and I50L/A71V double mutant HIV-protease with inhibitor TMC114 (darunavir…
Quantized water access to the HIV-1 protease active site as a proposed mechanism for cooperative mut…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism
Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients
Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kalet…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ